General Information of This Antibody-drug Conjugate (ADC)
ADC ID
DRG0NLWKV
ADC Name
SGN-CD19B
Synonyms
SGN CD19B; SGNCD19B
   Click to Show/Hide
Organization
Seagen Inc.
Drug Status
Terminated in phase 1
Indication
In total 2 Indication(s)
Diffuse large B-cell lymphoma [ICD11:2A81]
Terminated in phase 1
Follicular lymphoma [ICD11:2A80]
Terminated in phase 1
Drug-to-Antibody Ratio
2
Structure
Antibody Name
Anti-CD19 mAb hBU12ec
 Antibody Info 
Antigen Name
B-lymphocyte antigen CD19 (CD19)
 Antigen Info 
Payload Name
SGD-1882
 Payload Info 
Therapeutic Target
Human Deoxyribonucleic acid (hDNA)
 Target Info 
Linker Name
Mc-Val-Ala
 Linker Info 
Conjugate Type
Site-specific conjugation through the engineered cysteine (THIOMAB, Cys239).
Combination Type
SGD-1910
TTD ID
D02HHM

If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.